Episode

Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 1

Podcast: Neurology Minute
Published: Apr 29, 2026
Duration seconds: 257
Processing state: not_requested
Canonical source: https://neurologyminute.libsyn.com/maintenance-immunotherapy-in-mogad-early-steroid-benefit-dose-thresholds-and-disability-risk-part-1
Audio: https://traffic.libsyn.com/secure/neurologyminute/03_April_29th_2026_nm_v2.mp3?dest-id=1085030
JSON: /v1/public/podcasts/neurology-minute-15117/episodes/maintenance-immunotherapy-in-mogad-early-steroid-benefit-dose-thresholds-and-disability-risk-part-1
Markdown: /podcast/neurology-minute-15117/maintenance-immunotherapy-in-mogad-early-steroid-benefit-dose-thresholds-and-disability-risk-part-1.md

Actions

POST https://stenobird.com/v1/public/podcasts/neurology-minute-15117/episodes/maintenance-immunotherapy-in-mogad-early-steroid-benefit-dose-thresholds-and-disability-risk-part-1/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/neurology-minute-15117/maintenance-immunotherapy-in-mogad-early-steroid-benefit-dose-thresholds-and-disability-risk-part-1.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

In part one of this series, Dr. Justin Abbatemarco and Dr. Benjamin P. Trewin discuss the major findings from his work. Read more about this abstract on the AAN website .